Objective: Different fast track programs for patients undergoing radical cystectomy (RC) can be found in the current literature. The aim of this work was to develop a new enhanced recovery protocol (ERP). Patients and Methods: The ERP was designed after a structured literature review focusing on reduced bowel preparation, standardized feeding, postoperative nausea, vomiting and pain control. In order to test the ERP, a pilot observational prospective cohort study was planned, enrolling all patients consecutively undergoing RC and Vescica Ileale Padovana (VIP) neobladder. These patients were compared with a matched group of subjects who had undergone RC and VIP neobladder before implementation of the ERP. To achieve good comparability, a propensity score-matching was performed. The primary aim was to assess the ERP's feasibility; the secondary outcome measures were early morbidity and mortality. Results and Limitations: After an exhaustive literature search and a multidisciplinary consultation, an ERP was designed. Nine consecutive patients participated in the pilot study and were compared to 13 patients treated before implementation of the ERP. We did not find any statistically significant difference in terms of mortality rate (none died peri- or postoperatively in both groups). The complication rate, according to the modified Clavien classification, was significantly lower in the ERP group (22.22 vs. 84.61%, p < 0.004). The major limitations are the low number of patients enrolled to test the protocol and the lack of randomization for the comparative evaluations. Conclusion: The introduction of our ERP was proven to be feasible in the management of patients undergoing RC and intestinal urinary diversion with VIP neobladder. The postoperative course was enhanced by a significant reduction in both nasogastric tube insertion and parenteral nutrition support, with early postoperative feeding. All these findings were associated with no deleterious effect on morbidity or mortality, indeed there was a reduced occurrence of postoperative complication rates.

1.
Dahl JB, Hansen BL, Hjortso NC, et al: Influence of timing on the effect of continuous extradural analgesia with bupivacaine and morphine after major abdominal surgery. Br J Anaesth 1992;69:4-8.
2.
Moiniche S, Dahl JB, Rosenberg J, Kehlet H: Colonic resection with early discharge after combined subarachnoid-epidural analgesia, preoperative glucocorticoids, and early postoperative mobilization and feeding in a pulmonary high-risk patient. Reg Anesth 1994;19:352-356.
3.
Kehlet H, Wilmore DW: Multimodal strategies to improve surgical outcome. Am J Surg 2002;183:630-641.
4.
Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJHM: Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev 2011;2:CD007635.
5.
Pantelis D, Wolff M, Overhaus M, et al: ‘Fast-track surgery': perioperative management. Urologe A 2006;45:W1193-W1200.
6.
Chang SS, Cookson MS, Baumgartner RG, et al: Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002;167:2012-2016.
7.
Boström PJ, Kössi J, Laato M, et al: Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2009;103:191-196.
8.
Novara G, De Marco V, Aragona M, et al: Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914-921.
9.
Pruthi RS, Nielsen M, Smith A, et al: Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. J Am Coll Surg 2010;210:93-99.
10.
Stenzl A, Cowan NC, De Santis M, et al: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009;55:815-825.
11.
Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
12.
Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
13.
Dripps RD, Lamont A, Eckenhoff JE: The role of anesthesia in surgical mortality. JAMA 1961;178:261-266.
14.
Sobin LH, Gospodariwicz M, Wittekind C (eds): TNM Classification of Malignant Tumors. UICC International Union Against Cancer, ed 7. Chichester, Wiley-Blackwell, 2009, pp 262-265.
15.
Rubenstein LZ, Harker JO, Salva A, et al: Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001;56:M366-M372.
16.
Kaiser MJ, Bauer JM, Ramsch C, et al: Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 2009;13:782-788.
17.
Skinner DG, Lieskovsky G: Management of invasive high-grade bladder cancer; in Skinner DG, Lieskovsky G (eds): Diagnosis and Management of Genitourinary Cancer. Philadelphia, Saunders, 1987, pp 295-312.
18.
Pagano F, Artibani W, Ligato P, et al: Vescica Ileale Padovana: a technique for total bladder replacement. Eur Urol 1990;17:149-154.
19.
Stein JP, Skinner DG: Orthotopic urinary diversion; in Wein AJ, Kavoussi LR, Novick AC, Partin AW (eds): Campbell-Walsh Urology, ed 9. Philadelphia, Saunders, 2007.
20.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort 6,336 patients and results of a survey. Ann Surg 2004;240:205-213.
21.
Adamina M, Guller U, Weber WP, Oertli D: Propensity scores and the surgeon. Br J Surg 2006;93:389-394.
22.
Muller S, Zalunardo MP, Hubner M, et al: A fast track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology 2009;178:842-847.
23.
Velasco FT, Ko W, Rosengart T, et al: Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York Hospital-Cornell Medical Center. Best Pract Benchmarking Healthc 1996;1:21-28.
24.
Chang SS, Cole E, Smith JA Jr, et al: Safely reducing length of stay after open radical retropubic prostatectomy under the guidance of a clinical care pathway. Cancer 2005;104:747-751.
25.
Arumainayagam N, McGrath J, Jefferson KP, Gillatt DA: Introduction of an enhanced recovery protocol for radical cystectomy. BJU Int 2008;101:698-701.
26.
Olbert PJ, Baumann L, Hegele A, et al: Fast-track concepts in the perioperative management of patients undergoing radical cystectomy and urinary diversion: review of the literature and research results. Urologe A 2009;48:137-142.
27.
Shafii M, Murphy DM, Donovan MG, Hickey DP: Is mechanical bowel preparation necessary in patients undergoing cystectomy and urinary diversion? BJU Int 2002;89:879-881.
28.
Kouba EJ, Wallen EM: Gum chewing stimulates bowel motility in patients undergoing radical cystectomy with urinary diversion. J Urol 2007;70:1053-1056.
29.
Maffezzini M, Campodonico F, Capponi G, et al: Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch. Surg Oncol 2012;21:191-195.
30.
Saar M, Ohlmann CH, Siemer S, et al: Fast-track rehabilitation after robot-assisted laparoscopic cystectomy accelerates postoperative recovery. BJU Int 2013;112:E99-E106.
31.
Karl A, Seitz M, Staehler M, et al: Fast track approach in radical cystectomy. Urologe A 2011;50:1072-1075.
32.
Braga M, Ljungqvist O, Soeters P, et al: ESPEN Guidelines on Parenteral Nutrition: surgery. Clin Nutr 2009;28:378-386.
33.
White PF, Kehlet H, Neal JM, et al: The role of the anesthesiologist in fast-track surgery: from multimodal analgesia to perioperative medical care. Anesth Analg 2007;104:1380-1396.
34.
Agachan F, Chen T, Pfeifer J, et al: A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 1996;39:681-685.
35.
Friedrich-Freksa M, Schulz E, Nitzke T, et al: Cystectomy and urinary diversion in the treatment of bladder cancer without artificial respiration. Int Braz J Urol 2012;38:645-651.
36.
Karl A, Schneevoigt B, Weninger E, et al: Feasibility of radical cystectomy in exclusive spinal and/or epidural anaesthesia. World J Urol, E-pub ahead of print.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.